~~<i id='513135D20D'><strike id='513135D20D'><tt id='513135D20D'><pre id='513135D20D'></pre></tt></strike></i>~~

Home» comprehensive» explore

explore

author：comprehensive 2025-09-30 07:26:50 Page View：1

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： My superpower is killing ticks
Next article： ChatGPT in medicine: STAT answers readers' burning questions

Wikipedia

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

JaeC.Hong/APRoughly7.7%ofAmericansdidn’thaveanyhealthinsuranceasofthispastMarch—a“recordlow”uninsure

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Verily hires former Apple Health leader as chief scientific officer

AndrewTrister,anoncologistandveteranofbigtechnologycompaniesandresearch,isVerily'snewchiefscientific